Showing results (1-10 of 421) with videos related to
Sort By:
Pageof 43
Expert Opinion on Pharmacotherapy|June 23, 2009
Fixed-dose combinations of renin-angiotensin blocking agents with calcium channel blockers or hydrochlorothiazide in the treatment of hypertensionPeter BramlageVascular Health and Risk Management|May 14, 2009
Fixed combination of irbesartan and hydrochlorothiazide in the management of hypertensionPeter BramlageClinical Drug Investigation|April 14, 2010
Candesartan cilexetil/hydrochlorothiazide treatment in high-risk patients with type 2 diabetes mellitus and microalbuminuria: the CHILI T2D studyReinhard Ketelhut, Peter BramlagePerfusion|July 17, 2016
Early improvement of symptoms using LCZ696 in a patient with systolic heart failure and a reduced ejection fraction: a case reportJohannes Kohlmeier, Peter BramlageExpert Opinion on Pharmacotherapy|December 25, 2009
Differences in pharmacology and their translation into differences in clinical efficacy--a comparison of the renin angiotensin blocking agents irbesartan and losartanPeter Bramlage, Christoph SchindlerThe Heart Surgery Forum|January 4, 2019
Use of the ClearSight® System for Continuous Noninvasive Hemodynamic Monitoring during Heart Valve Interventions: Review of the Literature and Single-Site ExperienceGeorge Gellert, Peter BramlageCurrent Diabetes Reports|February 12, 2013
Insulin use early in the course of type 2 diabetes mellitus: the ORIGIN trialMarkolf Hanefeld, Peter BramlageExpert Opinion on Pharmacotherapy|May 20, 2014
Vildagliptin , a DPP-4 inhibitor for the twice-daily treatment of type 2 diabetes mellitus with or without metforminThomas Forst, Peter BramlageCardiovascular Diabetology|March 31, 2009
Blood pressure reduction, persistence and costs in the evaluation of antihypertensive drug treatment--a reviewPeter Bramlage, Joerg HasfordBMC Pharmacology|October 31, 2008
Bioequivalence study of three ibuprofen formulations after single dose administration in healthy volunteersPeter Bramlage, Adrian GoldisPageof 43